NP684782.RAyJvqsCM82v-fPJOqiQCedqNaVGldQBijP0-5bglN5VA
has assertion: NP684782.RAyJvqsCM82v-fPJOqiQCedqNaVGldQBijP0-5bglN5VA130 assertion
has provenance: NP684782.RAyJvqsCM82v-fPJOqiQCedqNaVGldQBijP0-5bglN5VA130 provenance
has publication info: NP684782.RAyJvqsCM82v-fPJOqiQCedqNaVGldQBijP0-5bglN5VA130 publicationInfo
type: Nanopublication
created: 2015-08-25T14:44:33+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v3.0.0.0

NP684782.RAyJvqsCM82v-fPJOqiQCedqNaVGldQBijP0-5bglN5VA130 assertion
type: Assertion
description: [These observations identify CCL2 as a crucial mediator of the initiation and progression of chronic colitis-associated colon carcinogenesis and suggest that targeting CCL2 may be useful in treating colon cancers, particularly those associated with chronic inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/19773434
was generated by: ECO_0000203

befree-20150227
imported on: 2015-02-27

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v3.0.0